(Q33357056)

English

Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppression: long-term follow-up of hematopoiesis

scientific article published on October 2, 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppression: long-term follow-up of hematopoiesis (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Jean-Jacques Lataillade

8

object named as

Jean-Jacques Lataillade

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Michel Drouet

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Frédéric Mourcin

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nancy Grenier

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Valérie Leroux

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Josianne Denis

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jean-François Mayol

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Philippe Thullier

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Francis Herodin

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

2 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

full work available at URL

https://ashpublications.org/blood/article-pdf/103/3/878/1695270/zh800304000878.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525791

17 March 2024

http://ashpublications.org/blood/article-pdf/103/3/878/1695270/zh800304000878.pdf

Portable Document Format

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

103

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

878-885

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Haematopoietic growth factors in the treatment of therapeutic and accidental irradiation-induced bone marrow aplasia

1

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Criticality accidents in Vinca, Yugoslavia, and Oak Ridge, Tennessee. Comparison of radiation injuries and results of therapy

2

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Hematologic consequences of exposure to ionizing radiation

4

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia

10

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Promegapoietin-1a, an engineered chimeric IL-3 and Mpl-L receptor agonist, stimulates hematopoietic recovery in conventional and abbreviated schedules following radiation-induced myelosuppression in nonhuman primates

11

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Thrombocytopenia caused by the development of antibodies to thrombopoietin

13

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Single administration of thrombopoietin to lethally irradiated mice prevents infectious and thrombotic events leading to mortality

16

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Short-term injection of antiapoptotic cytokine combinations soon after lethal gamma -irradiation promotes survival

18

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34+ cell proliferation and differentiation

20

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Effects of the combination of thrombopoietin with cytokines on the survival of X-irradiated CD34(+) megakaryocytic progenitor cells from normal human peripheral blood

21

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis

22

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species.

23

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

THE EFFICIENT DESIGN OF TRANSPLANTABLE TUMOUR ASSAYS.

24

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Acute radiation disease and biological dosimetry in 1993.

25

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

The prolonged hematologic effects of a single injection of PEG-rHuMGDF in normal and thrombocytopenic mice

26

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Interleukin-7: from bench to clinic

29

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

In vivo expansion of hemopoietic stem cells

31

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Irradiation enhances the support of haemopoietic cell transmigration, proliferation and differentiation by endothelial cells.

32

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Non-targeted and Delayed Effects of Exposure to Ionizing Radiation: I. Radiation-Induced Genomic Instability and Bystander EffectsIn Vitro

33

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Modulation of intercellular communication mediated at the cell surface and on extracellular, plasma membrane-derived vesicles by ionizing radiation

34

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal

36

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on primitive hematopoietic stem cell (PHSC) function and numbers, after chemotherapy

37

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor

38

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Thrombopoietin therapy increases platelet yields in healthy platelet donors

39

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Immunogenicity of thrombopoietin mimetic peptide GW395058 in BALB/c mice and New Zealand white rabbits: evaluation of the potential for thrombopoietin neutralizing antibody production in man.

40

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Dosimetry for total body irradiation of rhesus monkeys with 300 kV X-rays

42

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Mobilized bone marrow cells repair the infarcted heart, improving function and survival

44

1 reference

10.1182/BLOOD-2003-05-1400

https://api.crossref.org/works/10.1182/BLOOD-2003-05-1400

17 March 2024

Identifiers

10.1182/BLOOD-2003-05-1400

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33357056&oldid=2106074991"